Maternal body weight and gestational diabetes differentially influence placental and pregnancy outcomes

Journal of Clinical Endocrinology and Metabolism

Volumn 101, Issue 1, 2016, Pages 59-68

  Martino, J ^a,b   Sebert, S ^a,f   Segura, M T ^b   Garcia Valdes L ^b   Florido, J ^b   Padilla, M C ^b   Marcos, A ^c   Rueda, R ^d   McArdle, H J ^e   Budge, H ^a   Symonds, M E ^a   Campoy, C ^b  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b UNIVERSITY OF GRANADA   (Spain)

^c INSTITUTE OF FOOD SCIENCE   (Spain)

^d ABBOTT LABORATORIES   (Spain)

^e ROWETT RESEARCH INSTITUTE   (United Kingdom)

^f UNIVERSITY OF OULU   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; LEPTIN; MAMMALIAN TARGET OF RAPAMYCIN; SIRTUIN 1; UNCOUPLING PROTEIN 2;

ADULT; AMPK GENE; ANTHROPOMETRY; ARTICLE; BIRTH WEIGHT; BLOOD SAMPLING; BODY MASS; BODY WEIGHT; CONTROLLED STUDY; ENERGY BALANCE; FEMALE; FETUS WEIGHT; GENE; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MATERNAL OBESITY; MTOR GENE; P70S6KB1 GENE; PLACENTA WEIGHT; PREGNANCY DIABETES MELLITUS; PREGNANCY OUTCOME; PRIORITY JOURNAL; SIRT 1 GENE; SPAIN; UCP2 GENE; UMBILICAL CORD BLOOD; ADOLESCENT; CALORIC INTAKE; COMPLICATION; EPIDEMIOLOGY; GENETICS; GLUCOSE INTOLERANCE; INFLAMMATION; LONGITUDINAL STUDY; METABOLISM; MIDDLE AGED; NEWBORN; OBESITY; OXIDATIVE STRESS; PATHOLOGY; PATHOPHYSIOLOGY; PLACENTA; PREGNANCY; YOUNG ADULT;

ADOLESCENT; ADULT; ANTHROPOMETRY; BIRTH WEIGHT; BODY MASS INDEX; BODY WEIGHT; DIABETES, GESTATIONAL; ENERGY INTAKE; FEMALE; GENE EXPRESSION; GLUCOSE INTOLERANCE; HUMANS; INFANT, NEWBORN; INFLAMMATION; LONGITUDINAL STUDIES; METABOLIC NETWORKS AND PATHWAYS; MIDDLE AGED; OBESITY; OXIDATIVE STRESS; PLACENTA; PREGNANCY; PREGNANCY OUTCOME; SPAIN; YOUNG ADULT;

EID: 84954560134     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2015-2590     Document Type: Article

References (81)

1. Viner RM, Cole TJ. Who changes body mass between adolescence and adulthood? Factors predicting change in BMI between 16 year and 30 years in the 1970 British Birth Cohort. Int J Obes (Lond). 2006;30:1368-1374.
2. Fitzsimons KJ, Modder J; Centre for Maternal and Child Enquires. Setting maternity care standards for women with obesity in pregnancy. Semin Fetal Neonatal Med. 2010;15(2):100-107.
3. Bautista-Castaño I, Alemán-Perez N, García-Salvador JJ, et al. [Prevalence of obesity in pregnant women of Canary Islands, Spain.] Med Clin (Barc). 2011;136:478-480. (Spanish).
4. Schafer-Graf U. The HAPO Study and its consequences for the diagnostic of gestational diabetes. Geburtshilfe Frauenheilkd. 2009; 69:259-261.
5. Dominguez LJ, Martínez-González MA, Basterra-Gortari FJ, et al. Fast food consumption and gestational diabetes incidence in the SUN Project. PLoS One. 2014;9:e106627.
6. Buckley BS, Harreiter J,DammP, et al. Gestational diabetes mellitus in Europe: Prevalence, current screening practice and barriers to screening. A review. Diabet Med. 2012;29:844-854.
7. Ehrenberg HM, Durnwald CP, Catalano P, Mercer BM. The influence of obesity and diabetes on the risk of cesarean delivery. Am J Obstet Gynecol. 2004;191:969-974.
8. Briley AL, Barr S, Badger S, et al.Acomplex intervention to improve pregnancy outcome in obese women; the UPBEAT randomised controlled trial. BMC Pregnancy Childbirth. 2014;14:74.
9. Symonds ME, Sebert SP, HyattMA,Budge H. Nutritional programming of the metabolic syndrome. Nat Rev Endocrinol. 2009;5:604-610.
10. Coustan DR, Carpenter MW, O'Sullivan PS, Carr SR. Gestational diabetes: Predictors of subsequent disordered glucose metabolism. Am J Obstet Gynecol. 1993;168:1139-1145.
11. HAPO Study Cooperative Research Group. Hyperglycaemia and Adverse Pregnancy Outcome (HAPO) Study: Associations with maternal body mass index. BJOG. 2010;117:575-584.
12. Mamun AA, Kinarivala M, O'Callaghan MJ, et al. Associations of excess weight gain during pregnancy with long-term maternal overweight and obesity: Evidence from 21 y postpartum follow-up.AmJ Clin Nutr. 2010;91:1336-1341.
13. Nohr EA, Vaeth M, Baker JL, Sørensen TI, Olsen J, RasmussenKM. Pregnancy outcomes related to gestational weight gain in women defined by their body mass index, parity, height, and smoking status. Am J Clin Nutr. 2009;90:1288-1294.
14. Catalano PM, Ehrenberg HM. The short-and long-term implications of maternal obesity on the mother and her offspring. BJOG. 2006;113:1126-1133.
15. Reynolds LP, Caton JS, Redmer DA, et al. Evidence for altered placental blood flow and vascularity in compromised pregnancies. J Physiol. 2006;572:51-58.
16. Jansson T, Wennergren M, Powell TL. Placental glucose transport and GLUT 1 expression in insulin-dependent diabetes. Am J Obstet Gynecol. 1999;180:163-168.
17. Magnusson AL, Waterman IJ, Wennergren M, Jansson T, Powell TL. Triglyceride hydrolase activities and expression of fatty acid binding proteins in the human placenta in pregnancies complicated by intrauterine growth restriction and diabetes. J Clin Endocrinol Metab. 2004;89:4607-4614.
18. Jauniaux E, Burton GJ. Villous histomorphometry and placental bed biopsy investigation in type I diabetic pregnancies. Placenta. 2006;27:468-474.
19. Catalano PM, Ehrenberg HM. The short-and long-term implications of maternal obesity on the mother and her offspring. BJOG. 2006;113:1126-1133.
20. Fraser A, Tilling K, Macdonald-Wallis C, et al. Associations of gestational weight gain with maternal body mass index, waist circumference, and blood pressure measured 16 y after pregnancy: The Avon Longitudinal Study of Parents and Children (ALSPAC). Am J Clin Nutr. 2011;93:1285-1292.
21. Challier JC, Basu S, Bintein T, et al. Obesity in pregnancy stimulates macrophage accumulation and inflammation in the placenta. Placenta. 2008;29:274-281.
22. Dubova EA, Pavlov KA, Borovkova EI, Bayramova MA, Makarov IO, Shchegolev AI. Vascular endothelial growth factor and its receptors in the placenta of pregnant women with obesity. Bull Exp Biol Med. 2011;151:253-258.
23. Colomiere M, Permezel M, Riley C, Desoye G, Lappas M. Defective insulin signaling in placenta from pregnancies complicated by gestational diabetes mellitus. Eur J Endocrinol. 2009;160:567-578.
24. Garvey WT, Maianu L, Zhu JH, Hancock JA, Golichowski AM. Multiple defects in the adipocyte glucose-transport system cause cellular insulin-resistance in gestational diabetes-heterogeneity in the number and a novel abnormality in subcellular-localization of Glut4 glucose transporters. Diabetes. 1993;42:1773-1785.
25. Jansson T, Aye IL, Goberdhan DC. The emerging role of mTORC1 signaling in placental nutrient-sensing. Placenta. 2012;33(Suppl 2): E23-e29.
26. Cunningham JT, Rodgers JT, Arlow DH, Vazquez F, Mootha VK, Puigserver P. mTOR controls mitochondrial oxidative function through a YY1-PGC-1alpha transcriptional complex. Nature. 2007;450:736-740.
27. Yan X, Zhu MJ, Xu W, et al. Up-regulation of Toll-like receptor 4/nuclear factor-kappa B signaling is associated with enhanced adipogenesis and insulin resistance in fetal skeletal muscle of obese sheep at late gestation. Endocrinology. 2010;151:380-387.
28. Louden E, Chi MM, Moley KH. Crosstalk between the AMP-activated kinase and insulin signaling pathways rescues murine blastocyst cells from insulin resistance. Reproduction. 2008;136:335-344.
29. Lee SC, Robson-Doucette CA, Wheeler MB. Uncoupling protein 2 regulates reactive oxygen species formation in islets and influences susceptibility to diabetogenic action of streptozotocin. J Endocrinol. 2009;203:33-43.
30. Holdsworth-Carson SJ, Lim R, Mitton A, et al. Peroxisome proliferator-activated receptors are altered in pathologies of the human placenta: Gestational diabetes mellitus, intrauterine growth restriction and preeclampsia. Placenta. 2010;31:222-229.
31. Torres-Espinola FJ, Berglund SK, García-Valdés LM, et al. Maternal obesity, overweight and gestational diabetes affect the offspring neurodevelopment at 6 and 18 months of age-a follow up from the PREOBE Cohort. PLoS One. 2015;10:e0133010.
32. Garcia-Valdes L, Campoy C, Hayes H, et al. The impact of maternal obesity on iron status, placental transferrin receptor expression and hepcidin expression in human pregnancy. Int J Obes (Lond). 2015; 39:517-578.
33. Sananes N, Guigue V, KohlerM,et al. Use of Z-scores to select a fetal biometric reference curve. Ultrasound Obstet Gynecol. 2009;34: 404-409.
34. Rasmussen KM, Yaktine AL. Weight Gain During Pregnancy: Reexamining the Guidelines. Washington, DC: The National Academies Press, 2009.
35. Lubchenco LO, Hansman C, Boyd E. Intrauterine growth in length and head circumference as estimated from live births at gestational ages from 26 to 42 weeks. Pediatrics. 1966;37:403-408.
36. Casas-Agustench P, López-Uriarte P, BullóM,Ros E, Gómez-Flores A, Salas-Salvadó J. Acute effects of three high-fat meals with different fat saturations on energy expenditure, substrate oxidation and satiety. Clin Nutr. 2009;28:39-45.
37. Hutchesson MJ, Rollo ME, Callister R, Collins CE. Self-monitoring of dietary intake by young women: Online food records completed on computer or smartphone are as accurate as paper-based food records but more acceptable. J Acad Nutr Diet. 2015;115:87-94.
38. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(T)(-Delta Delta C) method. Methods. 2001;25:402-408.
39. Mistry HD, Wilson V, Ramsay MM, Symonds ME, Broughton Pipkin F Reduced selenium concentrations and glutathione peroxidase activity in preeclamptic pregnancies. Hypertension. 2008;52:881-888.
40. Di Paolo S, Teutonico A, Leogrande D, Capobianco C, Schena PF. Chronic inhibition of mammalian target of rapamycin signaling downregulates insulin receptor substrates 1 and 2 and AKT activation: A crossroad between cancer and diabetes? J Am Soc Nephrol. 2006;17:2236-2244.
41. Jansson N, Rosario FJ, Gaccioli F, et al. Activation of placental mTORsignaling and amino acid transporters in obesewomengiving birth to large babies. J Clin Endocrinol Metab. 2013;98:105-113.
42. Roos S, Jansson N, Palmberg I, Säljö K, Powell TL, Jansson T. Mammalian target of rapamycin in the human placenta regulates leucine transport and is down-regulated in restricted fetal growth. J Physiol. 2007;582:449-459.
43. Wen HY, Abbasi S, Kellems RE, Xia Y. mTOR: A placental growth signaling sensor. Placenta. 2005;26(Suppl A):S63-S69.
44. Roberts VH, Smith J, McLea SA, Heizer AB, Richardson JL, Myatt L. Effect of increasing maternal body mass index on oxidative and nitrative stress in the human placenta. Placenta. 2009;30:169-175.
45. Wang Y, Walsh SW. Placental mitochondria as a source of oxidative stress in pre-eclampsia. Placenta. 1998;19:581-586.
46. Long YC, Zierath JR. AMP-activated protein kinase signaling in metabolic regulation. J Clin Invest. 2006;116:1776-1783.
47. Sharkey D, Gardner DS, Symonds ME, Budge H. Maternal nutrient restriction during early fetal kidney development attenuates the renal innate inflammatory response in obese young adult offspring. Am J Physiol Renal Physiol. 2009;297:F1199-F1207.
48. Pastor MD, García-Yébenes I, Fradejas N, et al. mTOR/S6 kinase pathway contributes to astrocyte survival during ischemia. J Biol Chem. 2009;284:22067-22078.
49. Ghosh HS, McBurney M, Robbins PD. SIRT1 negatively regulates the mammalian target of rapamycin. PLoS One. 2010;5:e9199.
50. Back JH, Rezvani HR, Zhu Y, et al. Cancer cell survival following DNAdamage-mediated premature senescence is regulated by mammalian target of rapamycin (mTOR)-dependent inhibition of sirtuin 1. J Biol Chem. 2011;286:19100-19108.
51. HyattMA,Gardner DS, Sebert S, et al. Suboptimal maternal nutrition, during early fetal liverdevelopment,promoteslipidaccumulationin the liver of obese offspring. Reproduction. 2011;141119-126.
52. Radaelli T, Lepercq J, Varastehpour A, Basu S, Catalano PM, Hauguel-De Mouzon S. Selective programming of feto-placental lipid pathways by gestational and pre-gestational diabetes. Reprod Sci. 2009;16:74a.
53. Gnanalingham MG1, Williams P, Wilson V, et al. Nutritional manipulation between early to mid-gestation: Effects on uncoupling protein-2, glucocorticoid sensitivity, IGF-I receptor and cell proliferation but not apoptosis in the ovine placenta. Reproduction. 2007; 134:615-623.
54. Elias E, Benrick A, Behre CJ, et al. Central nervous system lipocalintype prostaglandin D2-synthase is correlated with orexigenic neuropeptides, visceral adiposity and markers of the hypothalamic-pituitary-adrenal axis in obese humans. J Neuroendocrinol. 2011;23: 501-507.
55. Wang H, Ji J, Yu Y, et al. Neonatal overfeeding in female mice predisposes development of obesity in their male offspring via altered central leptin signaling. J Neuroendocrinol. 2015;27:600-608.
56. Ashworth CJ, Hoggard N, Thomas L, Mercer JG, Wallace JM, Lea RG. Placental leptin. Rev Reprod. 2000;5:18-24.
57. Lea RG, Howe D, Hannah LT, Bonneau O, Hunter L, Hoggard N. Placental leptin in normal, diabetic and fetal growth-retarded pregnancies. Mol Hum Reprod. 2000;6:763-769.
58. Farley DM, Choi J, Dudley DJ, et al. Placental amino acid transport and placental leptin resistance in pregnancies complicated by maternal obesity. Placenta. 2010;31:718-724.
59. Martin SS, Qasim A, Reilly MP. Leptin resistance: A possible interface of inflammation and metabolism in obesity-related cardiovascular disease. J Am Coll Cardiol. 2008;52:1201-1210.
60. Maymó JL, Pérez Pérez A, Maskin B, et al. The alternative Epac/cAMP pathway and the MAPK pathway mediate hCG induction of leptin in placental cells. PLoS One. 2012;7:e46216.
61. Gong DW, Bi S, Pratley RE, Weintraub BD. Genomic structure and promoter analysis of the human obese gene. J Biol Chem. 1996; 271:3971-3974.
62. Coya R, Gualillo O, Pineda J, et al. Effect of cyclic 3,5-adenosine monophosphate, glucocorticoids, and insulin on leptin messenger RNAlevels and leptin secretion in cultured human trophoblast. Biol Reprod. 2001;65:814-819.
63. Hayashi R,WadaH, Ito K, Adcock IM. Effects of glucocorticoids on gene transcription. Eur J Pharmacol. 2004;500:51-62.
64. Hauguel-de Mouzon S, Lepercq J, Catalano P. The known and unknown of leptin in pregnancy. Am J Obstet Gynecol. 2006;194: 1537-1545.
65. Bifulco G, Trencia A, Caruso M, et al. Leptin induces mitogenic effect on human choriocarcinoma cell line (JAr) via MAP kinase activation in a glucose-dependent fashion. Placenta. 2003;24:385-391.
66. Bouret SG, Draper SJ, Simerly RB. Trophic action of leptin on hypothalamic neurons that regulate feeding. Science. 2004;304:108-110.
67. Lepercq J, Challier JC, Guerre-Millo M, et al. Prenatal leptin production: Evidence that fetal adipose tissue produces leptin. J Clin Endocrinol Metab. 2001;86:2409-2413.
68. Attig L, Brisard D, Larcher T, et al. Postnatal leptin promotes organ maturation and development in IUGR piglets. PLoS One. 2013;8: E64616.
69. Mouzaki A, Panagoulias I, Raptis G, Farri-Kostopoulou E. Cord blood leptin levels of healthy neonates are associated with IFNgamma production by cord blood T-cells. PLoS One. 2012;7: E40830.
70. Basu S, Haghiac M, Surace P, et al. Pregravid obesity associates with increased maternal endotoxemia and metabolic inflammation. Obesity (Silver Spring). 2011;19:476-482.
71. Tieu BC, Lee C, Sun H, et al. An adventitial IL-6/MCP1 amplification loop accelerates macrophage-mediated vascular inflammation leading to aortic dissection in mice. J Clin Invest. 2009;119:3637-3651.
72. Yu Z, Han S, Zhu J, Sun X, Ji C, Guo X. Pre-pregnancy body mass index in relation to infant birth weight and offspring overweight/obesity: A systematic review and meta-analysis. PLoS One. 2013;8: E61627.
73. Guelinckx I, Devlieger R, Mullie P, Vansant G. Effect of lifestyle intervention on dietary habits, physical activity, and gestational weight gain in obese pregnant women: A randomized controlled trial. Am J Clin Nutr. 2010;91:373-380.
74. Salmenhaara M, Uusitalo L, Uusitalo U, et al. Diet and weight gain characteristics of pregnant women with gestational diabetes. Diabetologia. 2009;52:S47.
75. Giacosa A, Barale R, Bavaresco L, et al. Cancer prevention in Europe: The Mediterranean diet as a protective choice. Eur J Cancer Prev. 2013;22:90-95.
76. Babio N, Toledo E, Estruch R, et al. Mediterranean diets and metabolic syndrome status in the PREDIMED randomized trial.CMAJ. 2014;186:E649-E57.
77. Salomon JA, Wang H, Freeman MK, et al. Healthy life expectancy for 187 countries, 1990-2010: A systematic analysis for the Global Burden Disease Study 2010. Lancet. 2012;380:2144-2162.
78. Font JC, Fabbri C, Gil J. Decomposing cross-country differences in levels of obesity and overweight: Does the social environment matter? Soc Sci Med. 2010;70:1185-1193.
79. Bartholome LT, Peterson RE, Raatz SK, Raymond NC.Acomparison of the accuracy of self-reported intake with measured intake of a laboratory overeating episode in overweight and obese women with and without binge eating disorder. Eur J Nutr. 2013;52:193-202.
80. Poppitt SD, Swann D, Black AE, Prentice AM. Assessment of selective under-reporting of food intake by both obese and non-obese women in a metabolic facility. Int J Obesity Relat Metab Disord. 1998;2:303-311.
81. Bashiri A,HeoHJ, Ben-Avraham D, et al. Pregnancy complicated by obesity induces global transcript expression alterations in visceral and subcutaneous fat. Mol Genet Genomics. 2014;289:695-705.